WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read MorePfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read MoreThe update is aimed at strengthening local and national surveillance
Read MoreThe company is preparing to submit the results to the FDA this year
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479